{"disease":{"id":"overall-response-rate","name":"overall response rate"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06531681","title":"Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"The Second Affiliated Hospital of Hainan Medical University","has_results":false},{"nct_id":"NCT03892577","title":"Real-world Study for Patients With Advanced Hepatobiliary Tumors","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT07090525","title":"Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Qingdao Central Hospital","has_results":false},{"nct_id":"NCT06277024","title":"A Study on the Safety and Efficacy of the Combination of Candenizumab, Lenvatinib, and SOX Regimen in the Treatment of HER2 Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Fujian Medical University","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}